Short answer
Alpha Teknova, Inc. (TKNO) filed an 8-K current report with the SEC on August 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 financial results for quarter ended June 30, 2026.
Alpha Teknova, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 financial results for quarter ended June 30, 2026
- Press release issued August 5, 2026, containing detailed results
- Exhibit 99.1 provides the substantive earnings information for investor review
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $12.2M, up 18%, with Lab Essentials and Clinical Solutions each growing 18%
- 2026 revenue guidance raised to $45–47M, signaling sustained demand and improved confidence in biotech-market recovery
- Gross margin improved to 40.1% from 38.7%, while net loss narrowed to $3.2M from $3.6M
- Free cash outflow fell to $0.6M from $2.3M; full-year outlook improved to less than $8M
- Cash and short-term investments totaled $17.4M against $13.2M borrowings, while Build-Tek adds an AI-enabled product-development channel
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Alpha Teknova, Inc. 8-K filings
Get the next TKNO 8-K as it lands
Follow TKNO for push alerts, or ask the research agent what this filing means.